To clarify the clinical implication of the above-mentioned findings in vitro, expression levels of c-Met, Axl and PDGFR-α were examined by immunohistochemistry in a total of 65 cases of locally advanced and metastatic bladder tumors. The gene discussed is AXL; the disease is urinary bladder neoplasm.